[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100386031":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":12,"centralContacts":17,"locations":27,"responsibleParty":107,"collaborators":7,"id":109,"slug":110,"hasResults":111,"nctId":112,"briefTitle":113,"officialTitle":113,"acronym":7,"eligibilityCriteria":114,"healthyVolunteers":115,"sex":116,"minAge":117,"maxAge":118,"enrollmentInfo":119,"targetDuration":7,"studyType":122,"phases":7,"briefSummary":123,"conditions":124,"keywords":128,"overallStatus":30,"whyStopped":7,"lastUpdateSubmitDate":134,"lastUpdatePostDateStruct":135,"startDateStruct":138,"completionDateStruct":140,"leadSponsor":142,"locationsCount":143},{"fullName":5,"class":6},"University of Aarhus","OTHER",null,[9],{"type":6,"name":10,"description":11,"armGroupLabels":7,"otherNames":7},"Cognitive tests and Patient Reported Outcomes","Each patient will undergo cognitive tests and questionnaires",[13],{"name":14,"affiliation":15,"role":16},"Lene Haldbo-Classen, M.D","Aarhus University Hospital","PRINCIPAL_INVESTIGATOR",[18,23],{"name":19,"role":20,"phone":21,"phoneExt":7,"email":22},"Morten Høyer, MD","CONTACT","+45 2328 2823","morthoey@rm.dk",{"name":24,"role":20,"phone":25,"phoneExt":7,"email":26},"Lene Haldbo-Classen, MD","+4523342761","lenhaldb@rm.dk",[28,47,66,77,92],{"facility":29,"status":30,"city":31,"state":32,"zip":33,"country":34,"countryCode":35,"cosmosGeoPoint":36,"geoPoint":41,"contacts":42},"Department of Oncology, Rigshospitalet","RECRUITING","Copenhagen","Capital Region","2100","Denmark","DK",{"type":37,"coordinates":38},"Point",[39,40],12.56553,55.67594,{"lat":40,"lon":39},[43],{"name":44,"role":20,"phone":45,"phoneExt":7,"email":46},"Aida Muhic","+45 35456942","aida.muhic@regionh.dk",{"facility":48,"status":30,"city":49,"state":50,"zip":51,"country":34,"countryCode":35,"cosmosGeoPoint":52,"geoPoint":56,"contacts":57},"Danish Center for Particel Therapy","Aarhus","Region Midt","8200",{"type":37,"coordinates":53},[54,55],10.21076,56.15674,{"lat":55,"lon":54},[58,61,64],{"name":59,"role":20,"phone":60,"phoneExt":7,"email":22},"Morten Høyer","+452328 2823",{"name":62,"role":20,"phone":63,"phoneExt":25,"email":26},"Lene Haldbo-Classen","+45 2334 2761",{"name":65,"role":16,"phone":7,"phoneExt":7,"email":7},"Petra Witt",{"facility":67,"status":30,"city":49,"state":50,"zip":51,"country":34,"countryCode":35,"cosmosGeoPoint":68,"geoPoint":70,"contacts":71},"Department of Oncology, Aarhus University Hospital",{"type":37,"coordinates":69},[54,55],{"lat":55,"lon":54},[72,76],{"name":73,"role":20,"phone":74,"phoneExt":7,"email":75},"Slavka Lucakova","+45 3027 2470","slvkluka@rm.dk",{"name":62,"role":16,"phone":7,"phoneExt":7,"email":7},{"facility":78,"status":30,"city":79,"state":80,"zip":81,"country":34,"countryCode":35,"cosmosGeoPoint":82,"geoPoint":86,"contacts":87},"Department of Oncology, Aalborg University Hospital","Aalborg","Region Nord","9000",{"type":37,"coordinates":83},[84,85],9.9187,57.048,{"lat":85,"lon":84},[88],{"name":89,"role":20,"phone":90,"phoneExt":7,"email":91},"Charlotte Haslund","+45 97661414","cah@rn.dk",{"facility":93,"status":30,"city":94,"state":95,"zip":96,"country":34,"countryCode":35,"cosmosGeoPoint":97,"geoPoint":101,"contacts":102},"Department of Oncology, Odense University Hospital","Odense","Region Syd","5000",{"type":37,"coordinates":98},[99,100],10.38831,55.39594,{"lat":100,"lon":99},[103],{"name":104,"role":20,"phone":105,"phoneExt":7,"email":106},"Rikke Dahlrot","+45 26242142","rikke.dahlrot@rsyd.dk",{"type":108,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100386031","cognitive-function-after-radiation-therapy-for-primary-brain-tumours-100386031",false,"NCT04306432","Cognitive Function After Radiation Therapy for Primary Brain Tumours","Inclusion Criteria:\n\n* 18 years or older and Danish speaking.\n* Performance status WHO 0-2\n* Capable of cooperating on testing\n* Tumour histology (WHO 2016 classification) of the following types: anaplastic astrocytoma (IDH mutant), diffuse astrocytoma (IDH-mutant), gemistocytic astrocytoma (IDH mutant), diffuse astrocytoma (NOS), oligodendroglioma, meningioma, medulloblastoma (NOS), pituitary adenoma, other brain tumours including skull base sarcomas\n\nExclusion Criteria:\n\n* Glioblastoma\n* Performance status 3-4 (Karnofsky Performances of 60 or less)",true,"ALL","18 Years","100 Years",{"count":120,"type":121},300,"ESTIMATED","OBSERVATIONAL","This study will assess cognitive function in patients with a primary brain tumour treated with radiation therapy (RT) to generate radio-sensitivity and volume effect parameters for the development of cognitive dysfunction. All types of brain tumours apart from glioblastoma will be included.",[125,126,127],"Primary Brain Tumour","Radiation Toxicity","Cognitive Impairment",[129,130,131,132,133],"Brain tumour","Radiation therapy","Cognitive function","Hippocampus","Patient reported outcomes","2021-11-19",{"date":136,"type":137},"2021-12-02","ACTUAL",{"date":139,"type":137},"2019-01-03",{"date":141,"type":121},"2034-03-31",{"name":5,"class":6},5]